3Lankisch PG, Assmus C, Pflichthofer D, et al. Which etiology caus- es the most severe acute pancreatitis?. Int J Pancreatol, 1999,26:55- 57. 被引量：1
4Fortson MR, Freedman SN, Webster PD 3rd. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol, 1995,90:2134- 2139. 被引量：1
5Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am, 1990,19:783-791. 被引量：1
6Zheng M, Bai J, Yuan B, et al. Meta-analysis of prophylactic corti- costeroid use in post-ERCP pancreatitis. BMC Gastroenterology, 2008,8:1-8. 被引量：1
7Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-analysis of NSAIDs in the prevention of post-ERCP pancreatitis. Gut, 2008,57: 1262-1267. 被引量：1
8Mery CM, Rubio V, Duarte-Rojo A , et al. Android fat distribution as predictor of severity in acute pancreatitis. Pancreatology, 2002,2 : 543-549. 被引量：1
9Jaworek J, Bonior J, Pierzchalski P, et al. Leptin protects the pancreas from damage induced by caerulein overstimulation by modulating cytokine production. Pancreatology, 2002,2 : 89-99. 被引量：1
10Toskes pp. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am,1990,19:783-791. 被引量：1
